In a new article from, “FDA rules require medical device labelers to submit data to the Global Unique Device Identification Database (GUDID) for the highest-risk medical devices and will soon expand to moderate risk (Class II) devices in September 2016.  Collection of this data poses a set of issues for device makers, including where the data resides, how it is reviewed, and its eventual dissemination to stakeholders.”  Check out these tips for device makers facing the UDI system here: